Estimating incidence rates with misclassified disease status: a likelihood-based approach, with application to hepatitis C virus

Bureau, 2003, Applications of continuous time hidden Markov models to the study of misclassified disease outcomes, Stat Med, 22, 441, 10.1002/sim.1270 Smith, 2003, Estimation of infection and recovery rates for highly polymorphic parasites when detectability is imperfect, using hidden Markov models, Stat Med, 22, 1709, 10.1002/sim.1274 Meier, 2003, Discrete proportional hazards models for mismeasured outcomes, Biometrics, 59, 947, 10.1111/j.0006-341X.2003.00109.x Richardson, 2000, Product limit estimation for infectious disease data when the diagnostic test for the outcome is measured with uncertainty, Biostatistics, 1, 341, 10.1093/biostatistics/1.3.341 Yanagawa, 1984, Estimating disease rates from a diagnostic test, Am J Epidemiol, 119, 1015, 10.1093/oxfordjournals.aje.a113806 2004, Global burden of disease (GBD) for hepatitis C, J Clin Pharmacol, 44, 20, 10.1177/0091270003258669 El-Kamary, 2011, All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population, Clin Infect Dis, 53, 150, 10.1093/cid/cir306 Kim, 2002, The burden of hepatitis C in the United States, Hepatology, 36, S30, 10.1002/hep.1840360705 Fatma E, Way A. Egypt demographic and health survey 2008. Cairo, Egypt: Ministry of Health, El-Zanaty and Associates, and Macro International; 2009. Shebl, 2009, Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages, J Med Virol, 81, 1024, 10.1002/jmv.21480 Magder, 2005, Estimation of the risk of transmission of hepatitis C between spouses in Egypt based on seroprevalence data, Int J Epidemiol, 34, 160, 10.1093/ije/dyh370 Mohamed, 2005, Intrafamilial transmission of hepatitis C in Egypt, Hepatology, 42, 683, 10.1002/hep.20811 Mohamed, 2006, Transmission of hepatitis C virus between parents and children, Am J Trop Med Hyg, 75, 16, 10.4269/ajtmh.2006.75.16 Dussaix, 1994, Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody, J Clin Microbiol, 32, 2071, 10.1128/JCM.32.9.2071-2075.1994 Feucht, 1995, Study on reliability of commercially available hepatitis C virus antibody tests, J Clin Microbiol, 33, 620, 10.1128/JCM.33.3.620-624.1995 Burgess, 2002 Louis, 1982, Finding the observed information matrix when using the EM algorithm, J R Stat Soc Series B Stat Methodol, 44, 226 Burton, 2006, The design of simulation studies in medical statistics, Stat Med, 25, 4279, 10.1002/sim.2673 Tang, 2005, A comparison of imputation methods in a longitudinal randomized clinical trial, Stat Med, 24, 2111, 10.1002/sim.2099 Abdel-Hamid, 2002, Comparison of second- and third-generation enzyme immunoassays for detecting antibodies to hepatitis C virus, J Clin Microbiol, 40, 1656, 10.1128/JCM.40.5.1656-1659.2002 Ghosn, 2006, Increase in HCV incidence in HIV-1 infected patients followed since primary infection, Sex Transm Infect, 82, 458, 10.1136/sti.2006.021493 Bruandet, 2006, [Incidence and risk factors of HCV infection in a cohort of intravenous drug users in the North and East of France], Rev Epidemiol Sante Publique, 54 Izopet, 2005, Incidence of HCV infection in French hemodialysis units: a prospective study, J Med Virol, 77, 70, 10.1002/jmv.20415 Riggert, 1996, Risk of hepatitis C virus (HCV) transmission by anti-HCV-negative blood components in Austria and Germany, Ann Hematol, 72, 35, 10.1007/BF00663014 Copeland, 1977, Bias due to misclassification in the estimation of relative risk, Am J Epidemiol, 105, 488, 10.1093/oxfordjournals.aje.a112408 Magder, 1997, Logistic regression when the outcome is measured with uncertainty, Am J Epidemiol, 146, 195, 10.1093/oxfordjournals.aje.a009251 Le Strat, 1999, Monitoring epidemiologic surveillance data using hidden Markov models, Stat Med, 18, 3463, 10.1002/(SICI)1097-0258(19991230)18:24<3463::AID-SIM409>3.0.CO;2-I